Aline Van Pel
109 works · 9,644 citations · h-index 42
Top works
- Tumor Antigens Recognized by T Lymphocytes
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
- A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
- The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.
- Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cells
- Production of stable cytolytic T‐cell clones directed against autologous human melanoma
- Immunogenic (tum-) variants of mouse tumor P815: cloning of the gene of tum- antigen P91A and identification of the tum- mutation.
- Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
- Two tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
- Selection of highly transfectable variant from mouse mastocytoma P815
- Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.
- An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
- Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis.
- T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis
- Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes
- Immunogenic (tum−) variants obtained by mutagenesis of mouse mastocytoma P815
- Structure of the gene of tum‐ transplantation antigen P35B: presence of a point mutation in the antigenic allele.
- Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.
- Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma